ZEOX
Zeo ScientifiX, Inc.
Key Financials
Gross Profit
$4.3M
↑ 13.0%
Revenue
$5.2M
↑ 12.5%
Net Income
$-5521000
↓ 17.3%
EPS (Diluted)
$-0.86
↓ 16.2%
Operating Income
$-5386000
↓ 1.3%
Total Assets
$1.5M
↓ 7.1%
Shareholders' Equity
$-1423000.00
↑ 13.9%
Total Liabilities
$3.0M
↓ 10.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/4/2026 | View on SEC |
| SCHEDULE 13D/A | 7/24/2026 | View on SEC |
| SCHEDULE 13D/A | 7/24/2026 | View on SEC |
| SCHEDULE 13G/A | 7/24/2026 | View on SEC |
| S-8 | 7/24/2026 | View on SEC |
| 8-K | 7/21/2026 | View on SEC |
| 8-K | 7/8/2026 | View on SEC |
| 8-K | 7/1/2026 | View on SEC |
| 8-K | 6/16/2026 | View on SEC |
| 10-Q | 6/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZEOX |
| Company Name | Zeo ScientifiX, Inc. |
| CIK | 1557376 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1031 |
| State of Incorporation | NV |
| Phone | 888-963-7881 |